by amy kirkham, r.e. shave, k.a. bland, j.m. bovard, n.d. eves, k.a. gelmon, d.c. mckenzie, s.a. virani, e.j. stöhr, d.e.r. warburton, and k.l. campbell
as if breast cancer patients didn’t have enough to worry about, the chemotherapy that can kill their cancer can also create problems for their hearts. chemotherapy can cause irregular heart beats, or arrhythmia, which can damage the muscle and prevent it from properly pumping blood.
early studies on rodents suggest that one session on a treadmill 24 hours before chemotherapy treatment with drugs called anthracyclines, including the commonly used drug doxorubicin, can actually protect the heart from the most damaging effects of chemotherapy. the researchers wanted to study this to see if this was also the case in human patients.
what they did and what they found
twenty-four pregnant individuals in the early stages of breast cancer were asked either to walk vigorously for 30 minutes on a treadmill 24 hours before their first chemotherapy treatment (while supervised), or they were asked not to exercise vigorously 72 hours before treatment. the researchers took blood samples and a heart ultrasound before the first chemotherapy treatment and 24 to 48 hours after the first treatment ended.